Ovagen (20 mg)

Ovagen, a tripeptide bioregulator, should not be mistaken for the similarly named Ovagen containing ovine (sheep) follicle stimulating hormone (FSH). These two products possess distinct functions and are entirely dissimilar. While the FSH derivative aids ovulation, particularly in women dealing with conditions like polycystic ovarian syndrome (PCOS), the tripeptide serves as a liver function regulator. For the context of this article, Ovagen refers to the tripeptide bioregulator.

Developed by Dr. Vladimir Khavinson, Ovagen belongs to the Khavinson peptide family, created alongside numerous other peptides. Similar to other bioregulators, Ovagen can penetrate cell and nuclear membranes, directly influencing DNA structure and transcription patterns. Exhibiting tissue-specific effects like most bioregulatory peptides, the Glu-Asp-Leu peptide primarily regulates and normalizes liver and digestive tract functions. There’s also some indication suggesting its potential usefulness in managing the replication of the HIV virus. This particular discovery has sparked interest among HIV researchers seeking insights into the virus’s lifecycle.